Biohit Oyj

Regulatory Filings • Mar 27, 2020

Biohit oyj’s annual general meeting 2020

Biohit oyj’s annual general meeting 2020

Biohit Oyj

Stock Exchange Release

Biohit takes the threat of the Corona virus extremely seriously as a company
which promotes healthy of the people. Biohit has, based on the development of
the situation and the announcement by the Finnish Government decided to convene
the Annual General Meeting at a later stage when Corona virus does not anymore
cause any healthyrisks for for the meeting participants.

Helsinki, 27 March 2020

Biohit Oyj
Board of Directors

Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi (https://www.globenewswire.com/Tracker?data=PwLdjOY0
0JDDDIZWV3-Lmeo6BH0fdQLM9yb1zBCDsvs
-uICjtCkBIy2tb1HTruxXGgM0sytMst0SnnB9y_0blhIlfD1kTvAvK_YzHjWMSwTdVI9OEcvWOK6Hervm
ezWD)
www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=c5rWyQltbzVN
ETEAzPUZ5WLkdGhFEQ1oTBo35iEHNX-lvCr-94PYSU_QxddYHsnlfS_ChSNOY
-aUgD_x7sYeKlJobL86Vz2jeJMdEZy73CA3pSWmapSEFnK8HcdUe6Ek)

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and services
to promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share
(BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare
group. www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=c5rWy
QltbzVNETEAzPUZ5WLkdGhFEQ1oTBo35iEHNX8xhFJ8UXxKcBfwNUj1oaJLkJWDIfhT0_qN_43uOPrHsI
IWy25pE_7iX8aTY-nisGmlggNS87UH1ViJkQ-0ezca)